From: Risk of Parkinson’s disease following gout: a population-based retrospective cohort study in Taiwan
Patients with Gout | Patients without Gout | Rate ratio (95% CI) | P value | |||
---|---|---|---|---|---|---|
No. of Parkinson Disease | Per 1000 person-years | No. of Parkinson Disease | Per 1000 person-years | |||
Total | 339 | 3.56 | 247 | 2.63 | 1.36 (1.15–1.60) | <.001* |
Age | ||||||
≥ 65 | 214 | 12.37 | 159 | 9.31 | 1.33 (1.08–1.64) | .006* |
< 65 | 125 | 1.60 | 88 | 1.14 | 1.40 (1.06–1.86) | .015* |
Sex | ||||||
Male | 204 | 3.13 | 154 | 2.41 | 1.30 (1.05–1.62) | .013* |
Female | 135 | 4.49 | 93 | 3.10 | 1.45 (1.11–1.91) | .006* |
Follow-up | ||||||
0–1 | 33 | 702.13 | 17 | 257.58 | 2.73 (1.48–5.22) | <.001* |
1–5 | 90 | 62.54 | 65 | 37.06 | 1.69 (1.21–2.36) | <.001* |
≥ 5 | 216 | 2.30 | 165 | 1.79 | 1.29 (1.05–1.59) | .014* |